{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:42Z","timestamp":1787003742332,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Province Medical Science and Technology Research Program","award":["LHGJ20230352, LHGJ20240314"],"award-info":[{"award-number":["LHGJ20230352, LHGJ20240314"]}]},{"name":"Henan Medical Science and Technology Research and Development Program","award":["201702078"],"award-info":[{"award-number":["201702078"]}]},{"name":"Young and middle-aged innovative talents in health science and technology in Henan Province","award":["201004118"],"award-info":[{"award-number":["201004118"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25964-8","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:34:40Z","timestamp":1764164080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oxidative stress reactivates androgen receptor signaling via USP36 to drive castration resistance in prostate cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Changhui","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"7","key":"25964_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/pros.24323","volume":"82","author":"JM Liu","year":"2022","unstructured":"Liu, J. M., Chen, Y. T., Wu, C. T., Hsu, W. L. & Hsu, R. J. Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases. Prostate 82(7), 809\u2013815. https:\/\/doi.org\/10.1002\/pros.24323 (2022).","journal-title":"Prostate"},{"key":"25964_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030689","author":"J Morote","year":"2022","unstructured":"Morote, J., Aguilar, A., Planas, J. & Trilla, E. Definition of castrate resistant prostate cancer: New insights. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines10030689 (2022).","journal-title":"Biomedicines"},{"issue":"32","key":"25964_CR3","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1200\/jco.2005.03.4777","volume":"23","author":"HI Scher","year":"2005","unstructured":"Scher, H. I. & Sawyers, C. L. Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 23(32), 8253\u20138261. https:\/\/doi.org\/10.1200\/jco.2005.03.4777 (2005).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"9","key":"25964_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman, H. J. & Zhang, H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 20(9), 689\u2013709. https:\/\/doi.org\/10.1038\/s41573-021-00233-1 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"25964_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","volume":"17","author":"MD Jelic","year":"2021","unstructured":"Jelic, M. D., Mandic, A. D., Maricic, S. M. & Srdjenovic, B. U. Oxidative stress and its role in cancer. J. Cancer Res.Ther. 17(1), 22\u201328. https:\/\/doi.org\/10.4103\/jcrt.JCRT_862_16 (2021).","journal-title":"J. Cancer Res.Ther."},{"issue":"7","key":"25964_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.freeradbiomed.2011.07.011","volume":"51","author":"M Shiota","year":"2011","unstructured":"Shiota, M., Yokomizo, A. & Naito, S. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer. Free Radic. Biol. Med. 51(7), 1320\u20131328. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.07.011 (2011).","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"25964_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41388-019-0991-3","volume":"39","author":"T Feng","year":"2020","unstructured":"Feng, T. et al. TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression. Oncogene 39(2), 356\u2013367. https:\/\/doi.org\/10.1038\/s41388-019-0991-3 (2020).","journal-title":"Oncogene"},{"issue":"19","key":"25964_CR8","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1158\/1078-0432.Ccr-08-0591","volume":"14","author":"N Sharifi","year":"2008","unstructured":"Sharifi, N., Hurt, E. M., Thomas, S. B. & Farrar, W. L. Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: Implications for castration-resistant prostate cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 14(19), 6073\u20136080. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0591 (2008).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"25964_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.redox.2018.03.017","volume":"17","author":"P Gonzalez-Menendez","year":"2018","unstructured":"Gonzalez-Menendez, P. et al. GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress. Redox Biol. 17, 112\u2013127. https:\/\/doi.org\/10.1016\/j.redox.2018.03.017 (2018).","journal-title":"Redox Biol."},{"issue":"4","key":"25964_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4), 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"25964_CR11","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.28407956.v1","author":"Bo Zhou","year":"2025","unstructured":"Zhou, Bo. Supplementary figures. Figshare. Fig. https:\/\/doi.org\/10.6084\/m9.figshare.28407956.v1 (2025)."},{"key":"25964_CR12","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.28407959.v1","author":"Bo Zhou","year":"2025","unstructured":"Zhou, Bo. Supplementary tables. Figshare. Dataset. https:\/\/doi.org\/10.6084\/m9.figshare.28407959.v1 (2025)."},{"issue":"5","key":"25964_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/neuonc\/noac238","volume":"25","author":"G Chang","year":"2023","unstructured":"Chang, G. et al. USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5. Neuro. Oncol. 25(5), 841\u2013853. https:\/\/doi.org\/10.1093\/neuonc\/noac238 (2023).","journal-title":"Neuro. Oncol."},{"issue":"12","key":"25964_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41419-022-05474-5","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. Cell Death Dis. 13(12), 1021. https:\/\/doi.org\/10.1038\/s41419-022-05474-5 (2022).","journal-title":"Cell Death Dis."},{"issue":"2","key":"25964_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo, B. et al. ROS in cancer therapy: the bright side of the moon. Exp. Mol. Med. 52(2), 192\u2013203. https:\/\/doi.org\/10.1038\/s12276-020-0384-2 (2020).","journal-title":"Exp. Mol. Med."},{"key":"25964_CR16","doi-asserted-by":"publisher","first-page":"4350965","DOI":"10.1155\/2016\/4350965","volume":"2016","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. ROS and ROS-Mediated cellular signaling. Oxid. Med. Cell. Longev. 2016, 4350965. https:\/\/doi.org\/10.1155\/2016\/4350965 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"25964_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.20517\/cdr.2020.71","volume":"4","author":"D Mondal","year":"2021","unstructured":"Mondal, D. et al. Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators. Cancer Drug Resist. 4(1), 96\u2013124. https:\/\/doi.org\/10.20517\/cdr.2020.71 (2021).","journal-title":"Cancer Drug Resist."},{"issue":"2","key":"25964_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/onc.2009.322","volume":"29","author":"M Shiota","year":"2010","unstructured":"Shiota, M. et al. Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression. Oncogene 29(2), 237\u2013250. https:\/\/doi.org\/10.1038\/onc.2009.322 (2010).","journal-title":"Oncogene"},{"issue":"3","key":"25964_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/annonc\/mdw646","volume":"28","author":"M Shiota","year":"2017","unstructured":"Shiota, M. et al. Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 28(3), 569\u2013575. https:\/\/doi.org\/10.1093\/annonc\/mdw646 (2017).","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"25964_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1200\/go.20.00290","volume":"6","author":"IE Bassey","year":"2020","unstructured":"Bassey, I. E. et al. Impact of androgen deprivation on oxidative stress and antioxidant status in nigerian patients with prostate cancer undergoing androgen deprivation therapy. JCO. Glob. Oncol. 6, 1481\u20131489. https:\/\/doi.org\/10.1200\/go.20.00290 (2020).","journal-title":"JCO. Glob. Oncol."},{"issue":"6","key":"25964_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ccr.2009.11.006","volume":"16","author":"G Attard","year":"2009","unstructured":"Attard, G., Cooper, C. S. & de Bono, J. S. Steroid hormone receptors in prostate cancer: A hard habit to break?. Cancer Cell 16(6), 458\u2013462. https:\/\/doi.org\/10.1016\/j.ccr.2009.11.006 (2009).","journal-title":"Cancer Cell"},{"issue":"5","key":"25964_CR22","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.3892\/or.2017.5932","volume":"38","author":"N Khurana","year":"2017","unstructured":"Khurana, N. et al. Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer. Oncol. Rep. 38(5), 2774\u20132786. https:\/\/doi.org\/10.3892\/or.2017.5932 (2017).","journal-title":"Oncol. Rep."},{"issue":"1","key":"25964_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/pros.23251","volume":"77","author":"AT Szafran","year":"2017","unstructured":"Szafran, A. T. et al. High-content screening identifies Src family kinases as potential regulators of ar-v7 expression and androgen-independent cell growth. Prostate 77(1), 82\u201393. https:\/\/doi.org\/10.1002\/pros.23251 (2017).","journal-title":"Prostate"},{"issue":"6","key":"25964_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/pros.23307","volume":"77","author":"E Djusberg","year":"2017","unstructured":"Djusberg, E. et al. High levels of the AR-V7 splice variant and co-amplification of the golgi protein coding YIPF6 in AR amplified prostate cancer bone metastases. Prostate 77(6), 625\u2013638. https:\/\/doi.org\/10.1002\/pros.23307 (2017).","journal-title":"Prostate"},{"key":"25964_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom14050572","author":"MY Niu","year":"2024","unstructured":"Niu, M. Y. et al. The emerging role of ubiquitin-specific protease 36 (USP36) in cancer and beyond. Biomolecules https:\/\/doi.org\/10.3390\/biom14050572 (2024).","journal-title":"Biomolecules"},{"key":"25964_CR26","doi-asserted-by":"publisher","first-page":"795633","DOI":"10.3389\/fonc.2021.795633","volume":"11","author":"W Qiu","year":"2021","unstructured":"Qiu, W. et al. PRL1 promotes glioblastoma invasion and tumorigenesis via activating USP36-mediated snail2 deubiquitination. Front. Oncol. 11, 795633. https:\/\/doi.org\/10.3389\/fonc.2021.795633 (2021).","journal-title":"Front. Oncol."},{"issue":"6","key":"25964_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.31083\/j.fbl2706190","volume":"27","author":"W Sun","year":"2022","unstructured":"Sun, W. et al. Gene signature and prognostic value of ubiquitin-specific proteases members in hepatocellular carcinoma and explored the immunological role of USP36. Front. Biosci. 27(6), 190. https:\/\/doi.org\/10.31083\/j.fbl2706190 (2022).","journal-title":"Front. Biosci."},{"issue":"39","key":"25964_CR28","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1038\/s41388-022-02439-y","volume":"41","author":"H Ling","year":"2022","unstructured":"Ling, H. et al. CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1. Oncogene 41(39), 4433\u20134445. https:\/\/doi.org\/10.1038\/s41388-022-02439-y (2022).","journal-title":"Oncogene"},{"issue":"6","key":"25964_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/15384101.2022.2139554","volume":"22","author":"H Wu","year":"2023","unstructured":"Wu, H. et al. miR-140\u20133p\/usp36 axis mediates ubiquitination to regulate PKM2 and suppressed the malignant biological behavior of breast cancer through Warburg effect. Cell Cycle 22(6), 680\u2013692. https:\/\/doi.org\/10.1080\/15384101.2022.2139554 (2023).","journal-title":"Cell Cycle"},{"issue":"23","key":"25964_CR30","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1182\/blood.2019000381","volume":"134","author":"B Li","year":"2019","unstructured":"Li, B. et al. MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer\/T-cell lymphoma. Blood 134(23), 2046\u20132058. https:\/\/doi.org\/10.1182\/blood.2019000381 (2019).","journal-title":"Blood"},{"issue":"1","key":"25964_CR31","doi-asserted-by":"publisher","first-page":"13146","DOI":"10.1038\/s41598-018-31567-3","volume":"8","author":"PA de Las","year":"2018","unstructured":"de Las, P. A., Reiner, T., De Cesare, V., Trost, M. & Perez-Stable, C. Inhibiting multiple deubiquitinases to reduce androgen receptor expression in prostate cancer cells. Sci. Rep. 8(1), 13146. https:\/\/doi.org\/10.1038\/s41598-018-31567-3 (2018).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25964-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:34:41Z","timestamp":1764164081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25964-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25964"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25964-8","relation":{"references":[{"id-type":"doi","id":"10.6084\/m9.figshare.28407956.v1","asserted-by":"subject"},{"id-type":"doi","id":"10.6084\/m9.figshare.28407959.v1","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42185"}}